PNC Financial Services Group’s Day One Biopharmaceuticals DAWN Stock Holding History

PNC Financial Services Group’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$879	Buy	41 +10	+32%	+$141	﹤0.01%	4785
2025 Q4	$289	Sell	31 -16	-34%	-$134	﹤0.01%	4936
2025 Q3	$331	Sell	47 -373	-89%	-$2.57K	﹤0.01%	4873
2025 Q2	$2.73K	Buy	+420	New	+$2.89K	﹤0.01%	4321
2024 Q4	–	Sell	-3	Closed	-$42	–	4809
2024 Q3	$42	Buy	+3	New	+$43	﹤0.01%	4750
2024 Q1	–	Sell	-61	Closed	-$891	–	4718
2023 Q4	$891	Buy	61 +57	+1,425%	+$691	﹤0.01%	4334
2023 Q3	$49	Buy	+4	New	+$52	﹤0.01%	4578
2022 Q2	–	Sell	-175	Closed	-$2K	–	4535
2022 Q1	$2K	Buy	+175	New	+$2.31K	﹤0.01%	4177

Other funds holding DAWN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

PNC Financial Services Group's DAWN Position: Q1 2026 in Review

PNC Financial Services Group increased its Day One Biopharmaceuticals (DAWN) stake by 32% in Q1 2026, buying an estimated $141 and bringing the position to 41 shares worth $879. The position accounts for ﹤0.01% of the portfolio, ranked #4785.

PNC Financial Services Group first reported a position in DAWN in Q1 2022 and has held it in 8 quarters since. The position peaked at $2.73K in Q2 2025. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

PNC Financial Services Group held 41 shares of Day One Biopharmaceuticals worth $879 as of Q1 2026.
PNC Financial Services Group bought 10 Day One Biopharmaceuticals shares in Q1 2026, an estimated $141.
Day One Biopharmaceuticals made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #4785 holding.
PNC Financial Services Group first reported a position in Day One Biopharmaceuticals in Q1 2022 and has held it in 8 quarters since.
PNC Financial Services Group's Day One Biopharmaceuticals position peaked at $2.73K in Q2 2025.
206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.